Quote on Hester Biosciences Limited, stock up by 12% by Mr. Yash Gupta, Angel Broking Ltd
Below is quote on Hester Biosciences Limited, stock up by 12% by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd
Hester Bioscience Ltd up by 12% on back of a strong set of numbers for Q1FY22.
Hester Bioscience reported top line growth of 50% at ₹585 crores from ₹288 crores on back of strong performance of Poultry Healthcare division which is up by 61%to ₹481 crores while Animal Healthcare up by 16% to ₹104 crores. Net profit has increased from ₹76 crores to ₹122 crores up by 60% in Q1FY2022.
Heaster bioscience reported a very good set of numbers, top line up by 50% and bottom line up by 60% along with this company reported healthy EBITDA margin of 31.02%. Company's project to build capacity to manufacture a Drug Substance for Covaxin is going as per the timeline. We have a positive view on Hester Bioscience ltd.
Above views are of the author and not of the website kindly read disclaimer
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One